Esophageal cancer
Conditions
Interventions
ERAS group:Enhanced recovery after surgery
Sponsors
Department of Cardiothoracic Surgery, Nanjing General Hospital of Nanjing Military Region
Eligibility
Sex/Gender
Male
Age
20 Years to 79 Years
Inclusion criteria
Inclusion criteria: 1) Aged 20 to 80 years old man and woman; 2) Patients diagnosed as esophageal cancer by gastroscopy and pathology; no more than 7.5% of weight loss in the first three months of surgery; 3) No surgical contraindications, and R0 resection of esophageal cancer in our hospital; 4) Voluntarily participate in the study and sign an informed consent form; 5) Subjects can follow the drug dose and visit plan; 6) Can objectively describe the symptoms, no serious infection, respiratory insufficiency, etc., can actively cooperate; 7) Non-pregnant, lactating women;
Exclusion criteria
Exclusion criteria: 1) Those who do not meet the inclusion criteria, or who are judged by the competent physician to be unfit to participate in the trial; 2) The general situation is poor, the symptoms cannot be described objectively, or serious infections, respiratory insufficiency, etc. cannot be actively cooperated; 3) suffering from diabetes, thyroid dysfunction and other metabolic diseases; 4) There is a history of preoperative radiotherapy and chemotherapy; 5) severe postoperative complications (anastomotic fistula, pulmonary infection, etc.); 6) Patients who have participated in other clinical trials within 3 months prior to the trial; 7) Those who suffer from allergic diseases and are allergic to the body; have a history of drug sensitivity similar to the drug structure, and have a history of allergies to narcotic drugs; 8) sponsors or researchers or their family members who are directly involved in the trial; 9) The relevant information is incomplete during the study period; 10) The investigator believes that there is no reason for being selected.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Scored Patient-Generated Subjective Global Assessment;Quality of Life;Body composition analysis;albumin;Prealbumin;Transferrin;Hospital stay; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS;Hospital costs;Blood glucose; | — |
Countries
China
Contacts
Public ContactYi Shen
Department of Cardiothoracic Surgery, Nanjing General Hospital of Nanjing Military Region
Outcome results
None listed